Announcement no. 03/2020
Revised guidance for 2019 based on preliminary results for Q4 2019
Össur revises its financial guidance due to soft prosthetics sales in the fourth quarter of 2019.The main reasons for soft sales in Q4 2019 are lower than expected sales to a certain customer and soft sales in a few key markets. The slowdown in sales in Q4 2019 is largely considered to be of a temporary nature.
Preliminary results suggest that sales for FY 2019 amounted to
Preliminary sales in Q4 2019 amounted to
The preliminary results have not been audited.
Based on the preliminary results, Össur now expects organic growth of ~5% for FY 2019 (previous ~6%) and EBITDA margin before special items of ~22% for FY 2019 (previous ~23%). Other guidance parameters remain unchanged.
For 2020, Össur expects organic growth to continue to be in line or above estimated market growth and continued gradual increase in underlying profitability. The financial guidance will be further specified as part of the 2019 annual report.
Össur will release its Q4 2019 interim report and 2019 annual report as scheduled on
Conference call details
Össur will host a conference call today, Tuesday
Link to webcast: https://edge.media-server.com/mmc/p/pp8j5ffd
To participate in the conference call please call one of the following telephone numbers:
DK: +45 35445577
SE: +46 856642651
US: +1 6319131422
Further information
David Hreidarsson, Investor Relations, dhreidarsson@ossur.com, +354 515 1380
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at http://www.ossur.com/investors
About Össur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. A recognized "Technology Pioneer," Össur focuses on improving people's mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports, by investing significantly in research and product development to create award-winning designs with consistently strong market positions. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. As part of Össur's long-standing commitment to social responsibility, the company has been a signatory to the United Nations Global Compact since 2011, and also participates in the Nasdaq Nordic and Baltic exchanges' voluntary guidelines for Environment, Social and Corporate Governance (ESG). Össur is headquartered in
https://news.cision.com/ossur-hf-/r/revised-guidance-for-2019-based-on-preliminary-results-for-q4-2019,c3008383
https://mb.cision.com/Main/18404/3008383/1174077.pdf
(c) 2020 Cision. All rights reserved., source